PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
OLMA vs. UNFI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between OLMA and UNFI is 0.19, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

OLMA vs. UNFI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Olema Pharmaceuticals, Inc. (OLMA) and United Natural Foods, Inc. (UNFI). The values are adjusted to include any dividend payments, if applicable.

-50.00%0.00%50.00%100.00%AugustSeptemberOctoberNovemberDecember2025
-62.74%
93.37%
OLMA
UNFI

Key characteristics

Sharpe Ratio

OLMA:

-0.63

UNFI:

1.56

Sortino Ratio

OLMA:

-0.68

UNFI:

2.54

Omega Ratio

OLMA:

0.92

UNFI:

1.33

Calmar Ratio

OLMA:

-0.55

UNFI:

1.08

Martin Ratio

OLMA:

-1.44

UNFI:

4.40

Ulcer Index

OLMA:

34.51%

UNFI:

21.97%

Daily Std Dev

OLMA:

79.46%

UNFI:

61.83%

Max Drawdown

OLMA:

-96.26%

UNFI:

-93.50%

Current Drawdown

OLMA:

-89.61%

UNFI:

-65.78%

Fundamentals

Market Cap

OLMA:

$420.22M

UNFI:

$1.71B

EPS

OLMA:

-$2.44

UNFI:

-$1.60

Total Revenue (TTM)

OLMA:

$0.00

UNFI:

$31.30B

Gross Profit (TTM)

OLMA:

-$182.00K

UNFI:

$4.06B

EBITDA (TTM)

OLMA:

-$105.21M

UNFI:

$413.00M

Returns By Period

In the year-to-date period, OLMA achieves a -2.92% return, which is significantly lower than UNFI's 4.65% return.


OLMA

YTD

-2.92%

1M

-7.21%

6M

-62.64%

1Y

-49.82%

5Y*

N/A

10Y*

N/A

UNFI

YTD

4.65%

1M

10.43%

6M

101.98%

1Y

95.09%

5Y*

29.52%

10Y*

-9.82%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

OLMA vs. UNFI — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OLMA
The Risk-Adjusted Performance Rank of OLMA is 1414
Overall Rank
The Sharpe Ratio Rank of OLMA is 1414
Sharpe Ratio Rank
The Sortino Ratio Rank of OLMA is 1616
Sortino Ratio Rank
The Omega Ratio Rank of OLMA is 1717
Omega Ratio Rank
The Calmar Ratio Rank of OLMA is 1414
Calmar Ratio Rank
The Martin Ratio Rank of OLMA is 77
Martin Ratio Rank

UNFI
The Risk-Adjusted Performance Rank of UNFI is 8484
Overall Rank
The Sharpe Ratio Rank of UNFI is 8888
Sharpe Ratio Rank
The Sortino Ratio Rank of UNFI is 8787
Sortino Ratio Rank
The Omega Ratio Rank of UNFI is 8686
Omega Ratio Rank
The Calmar Ratio Rank of UNFI is 8181
Calmar Ratio Rank
The Martin Ratio Rank of UNFI is 7979
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

OLMA vs. UNFI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Olema Pharmaceuticals, Inc. (OLMA) and United Natural Foods, Inc. (UNFI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for OLMA, currently valued at -0.63, compared to the broader market-2.000.002.004.00-0.631.56
The chart of Sortino ratio for OLMA, currently valued at -0.68, compared to the broader market-4.00-2.000.002.004.006.00-0.682.54
The chart of Omega ratio for OLMA, currently valued at 0.92, compared to the broader market0.501.001.502.000.921.33
The chart of Calmar ratio for OLMA, currently valued at -0.55, compared to the broader market0.002.004.006.00-0.551.15
The chart of Martin ratio for OLMA, currently valued at -1.44, compared to the broader market-10.000.0010.0020.0030.00-1.444.40
OLMA
UNFI

The current OLMA Sharpe Ratio is -0.63, which is lower than the UNFI Sharpe Ratio of 1.56. The chart below compares the historical Sharpe Ratios of OLMA and UNFI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
-0.63
1.56
OLMA
UNFI

Dividends

OLMA vs. UNFI - Dividend Comparison

Neither OLMA nor UNFI has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

OLMA vs. UNFI - Drawdown Comparison

The maximum OLMA drawdown since its inception was -96.26%, roughly equal to the maximum UNFI drawdown of -93.50%. Use the drawdown chart below to compare losses from any high point for OLMA and UNFI. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%AugustSeptemberOctoberNovemberDecember2025
-89.61%
-48.61%
OLMA
UNFI

Volatility

OLMA vs. UNFI - Volatility Comparison

Olema Pharmaceuticals, Inc. (OLMA) has a higher volatility of 27.83% compared to United Natural Foods, Inc. (UNFI) at 11.54%. This indicates that OLMA's price experiences larger fluctuations and is considered to be riskier than UNFI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%AugustSeptemberOctoberNovemberDecember2025
27.83%
11.54%
OLMA
UNFI

Financials

OLMA vs. UNFI - Financials Comparison

This section allows you to compare key financial metrics between Olema Pharmaceuticals, Inc. and United Natural Foods, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab